87272-20-6CC(C)(CCCCCCCCCCC(C)(C)CC(=O)O)CC(=O)OHYSMCRNFENOHJH-UHFFFAOYSA-NMEDICA 16 is an alpha,-dicarboxylic acid that is hexadecanedioic acid carrying methyl groups at positions 3 and 14. It is a free fatty acid 1 (FFA1/GPR40) receptor agonist and an ATP citrate lyase inhibitor, and exhibits hypolipidemic and antidiabetogenic properties. It has a role as an EC 2.3.3.8 (ATP citrate synthase) inhibitor, a hypoglycemic agent, an antilipemic drug, an EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor and a G-protein-coupled receptor agonist.
87272-20-6DTXSID00236246安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明MEDICA 16 is a β,β''-dimethyl hexadecanedioic acid which exhibits hypolipidemic and antidiabetogenic effects in the rat. In animals that were fed a diet which was 0.25% MEDICA 16 by weight, the hypolipidemic effect consisted of a 70-80% decrease in plasma chylomicrons and VLDL-triacylglycerols as well as a 40-60% decrease in plasma VLDL-cholestrol.
使用MEDICA 16 is a β,β'-dimethyl hexadecanedioic acid which exhibits hypolipidemic and antidiabetogenic effects in the rat. In animals that were fed a diet which was 0.25% MEDICA 16 by weight, the hypolipidemic effect consisted of a 70-80% decrease in plasma chylomicrons and VLDL-triacylglycerols as well as a 40-60% decrease in plasma VLDL-cholestrol.
読み込み中…
CHEMBL63829CHEBI:149582